Download past and current PDFs issues

Cardiovascular News Issue 28 - February 2013
download now
Highlights: -RESPECT seen as positive despite failure to meet endpoint -Stent type may affect antiplatelet therapy duration -TAVI complications by Max Baghai -Profile: Stefan D Anker

Cardiovascular News Issue 28 - February 2013 US Edition
download now
Highlights: -RESPECT seen as positive despite failure to meet endpoint -Stent type may affect antiplatelet therapy duration -TAVI complications by Max Baghai -Profile: Stefan D Anker

Cardiovascular News Issue 27 - October 2012
download now
Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with in-hospital mortality comparable to surgery -Profile: David Holmes

Cardiovascular News Issue 27 - October 2012 US edition
download now
Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with in-hospital mortality comparable to surgery -Profile: David Holmes

Cardiovascular News Issue 26 - August 2012 US edition
download now
Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy alone -Alain Cribier: 10 years of TAVI -Profile: Bernard Chevalier

Cardiovascular News Issue 26 - August 2012
download now
Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy alone -Alain Cribier: 10 years of TAVI -Profile: Bernard Chevalier

Cardiovascular News Issue 25 - May 2012
download now
Highlights: -TAVI as effective as surgery in high-risk patients at two years -Sustained blood pressure reduction achieved with renal denervation out to three years -MRI and arrhytmias by James White -Profile: John Ormiston

Cardiovascular News Issue 24 - February 2012 EU edition
download now
Highlights:
-iFR vasodilator-free measure of stenosis severity comparable to FFR
-PARTNER A: Transfemoral TAVI improves quality of life, costs vs. surgery
-MRI safe in patients with selected cardiac rhythm management devices
-Profile: Jeffrey Moses

Cardiovascular News Issue 24 - February 2012 US edition
download now
Highlights:
-iFR vasodilator-free measure of stenosis severity comparable to FFR
-PARTNER A: Transfemoral TAVI improves quality of life, costs vs. surgery
-MRI safe in patients with selected cardiac rhythm management devices
-Profile: Jeffrey Moses

Cardiovascular News Issue 23 - November 2011
download now
Highlights:
-Lower thrombosis risk with newer generation drug-eluting stents
-Intra-aortic balloon counterpulsation does not appear to provide benefit
-"Prasugrel or ticagrelor should be administered to patients at clinical high risk for stent thrombosis"
-Profile: Ulrich Sigwart

Cardiovascular News Issue 22 - August 2011
download now
Highlights:
-FFR-CT technique can cut unnecessary coronary procedures
-"TAVI should be performed with cerebral protection"
-Pioneer of interventional cardiology in China receives Ethica Award 2011
-Profile: Martyn Thomas

Cardiovascular News Issue 21 - May 2011
download now
Highlights:
-PARTNER find TAVI as good as surgery
-Absorb shows positive one-year safety and efficacy results
-Profile: Ralph Brindis

Cardiovascular News Issue 20 - Feb 2011
download now
Highlights
- New absorbable stent era begins
- TAVI improves quality of life in inoperable patients
- Profile: Roberto Ferrari

Cardiovascular News Issue 19 - Sept 2010
download now
Highlights
- ESC sees SHIFT in heart failure treatment
- FDA advisory committe recommends approval of tricagrelor for acute coronary syndromes
- Interview - George Dangas
- New Jupiter analysis

Cardiovascular News Issue 18 - Jul 2010
download now
Highlights
- "Encouraging" TAVI results in high-risk patients
- Bioresorbable stent one step closer to becoming reality
- Profile: Josep Brugada

Cardiovascular News Issue 17 - Apr 2010
download now
Highlights
- NO ACCORDance on role of fibrates
- Cypher versus ENDEAVOR trial results cause stir
- Profile: Christopher Paul Cannon

Cardiovascular News Issue 16 - Jan 2010
download now
Highlights
- Controversy surrounds long-term lipid lowering therapy
- SPIRIT IV and COMPARE trials show positive results
- Profile: Alfredo Galassi

Cardiovascular News Issue 15 - Sep 2009
download now
Highlights
- New drugs steal the spotlight at the ESC Congress
- SYNTAX at two years: Comparable outcomes for stenting and bypass surgery in complex patients
- Profile: Alfred Bove

Cardiovascular News Issue 14 - Aug 2009
download now
Highlights
- Drug-eluting stents "warranted" for infarction
- Syntax Score website: A tool for the best strategy
- Profile: Silvia Priori

Cardiovascular News Issue 13 - May 2009
download now
Highlights
- Percutaneous mitral valve repair takes off
- Antiplatelet agent prasugrel receives CE mark
- Profile: Christian Hamm

Cardiovascular News Issue 12 - Jan 2009
download now
Highlights
- JUPITER: reduced events in patients with low LDL cholesterol, raised CRP
- FFR-guided stenting improves outcomes with fewer devices in the FAME trial